Chugai Pharmaceutical Co., Ltd.

4:45 PM - 5:00 PM (PDT), Tuesday, June 14, 2022
Chugai Pharmaceutical is one of Japan’s leading research-based pharmaceutical companies with strengths in biotechnology products. Chugai, based in Tokyo, specializes in prescription pharmaceuticals and is listed on the 1st section of the Tokyo Stock Exchange. As an important member of the Roche Group, Chugai is actively involved in R&D activities in Japan and abroad. Specifically, Chugai is working to develop innovative products which may satisfy the unmet medical needs.
Ticker:
4519
Exchange:
Tokyo
Company Type:
Publicly Traded Company
Company HQ State:
Not Provided
Company HQ Country:
Japan
Year Founded:
Not Provided
Main Therapeutic Focus:
Lead Product in Development:
SKY59 (crovalimab)
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
Senior Vice President
Chugai Pharmaceutical Co., Ltd.